179 Circular regarding NOC for export of biological products (Vaccine and r-DNA products) under Form 29 license to manufacture drugs for purposes of examination, test or analysis 2016-Dec-13 237kb
In force — no superseding record on file.
f
3
File No. X-11026/143/16-BD Directorate General of Health Services Office of Drugs Controller General (India) (Biological Division)
,
:
Circular
Subject: NOC for export of biological products (Vaccine & r-DNA products) under Form 29 License to manufacture drugs for purposes of examination, test or analysis-regarding.
It is learnt that many applicants are requesting this office for issuance of export NOC for the batches manufactured under Form 29 License for commercial purpose.
In this regard, it is clarified that the product manufactured under Form 29 license can be exported only for the purpose of examination, test or analysis including clinical evaluation involving human subjects and not meant for commercial purposes as per Drugs and Cosmetics Rules.
Drugs Controller(Dr.Gen€rala(India)
To, 3 All Stakeholder through website of CDSCO ii. Zonal / Sub-zonal offices of CDSCO iii. All officers of CDSCO (HQ)
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 24462 --apply.